These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26946713)

  • 21. Comparison of intra-articular glucocorticoid injections with DMARDs versus DMARDs alone in rheumatoid arthritis.
    Menon N; Kothari SY; Gogna A; Sharma R
    J Assoc Physicians India; 2014 Aug; 62(8):673-6. PubMed ID: 25856933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of care in the rheumatic diseases: current status and future directions.
    Yazdany J; MacLean CH
    Curr Opin Rheumatol; 2008 Mar; 20(2):159-66. PubMed ID: 18349745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Topical therapy with corticosteroids in rheumatology].
    Alusík S
    Vnitr Lek; 2000 Apr; 46(4):243-5. PubMed ID: 11227179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Should we stop or continue conventional synthetic (including glucocorticoids) and targeted DMARDs before surgery in patients with inflammatory rheumatic diseases?'.
    Goodman S M; George M D
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32719151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local medical treatment in rheumatic diseases.
    Menkes CJ
    Curr Rheumatol Rep; 2001 Apr; 3(2):93-4. PubMed ID: 11286663
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intraarticular injections of hydrocortisone in present rheumatological practice; experience from 750 injections].
    FALLET GH; LAMBELET F
    Praxis; 1955 Aug; 44(33):741-6. PubMed ID: 13254617
    [No Abstract]   [Full Text] [Related]  

  • 27. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
    Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
    Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robin goodfellow.
    Rheumatology (Oxford); 2002 Sep; 41(9):1081. PubMed ID: 12209049
    [No Abstract]   [Full Text] [Related]  

  • 29. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
    Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
    Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biosimilars].
    Burmester GR; Müller-Ladner U
    Z Rheumatol; 2015 Oct; 74(8):670-1. PubMed ID: 26450433
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rheumatology 2009].
    Tarner IH; Müller-Ladner U
    Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1340-2. PubMed ID: 19517327
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenges in Implementing Treat-to-Target Strategies in Rheumatology.
    Ford JA; Solomon DH
    Rheum Dis Clin North Am; 2019 Feb; 45(1):101-112. PubMed ID: 30447739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances: rheumatology.
    Madhok R; Kerr H; Capell HA
    BMJ; 2000 Oct; 321(7265):882-5. PubMed ID: 11021871
    [No Abstract]   [Full Text] [Related]  

  • 34. [The intra-articular glucocorticoid injection; short-term success with potential side effects].
    Geraets SE; Gosens T
    Ned Tijdschr Geneeskd; 2016; 160():D814. PubMed ID: 27924737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New trends in rheumatology. The Danish Society of Rheumatology].
    Andersen LS; Gam AN; Hansen A; Kollerup G; Rasmussen C; Rasmussen JM; Schiøttz-Christensen B; Slot O; Thamsborg G
    Ugeskr Laeger; 2003 Mar; 165(12):1255. PubMed ID: 12701305
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental rheumatology--on the way to a fundamental understanding of rheumatic diseases].
    Radbruch A
    Z Rheumatol; 2005 Sep; 64(6):367-9. PubMed ID: 16184342
    [No Abstract]   [Full Text] [Related]  

  • 37. Key developments in rheumatology.
    Panthakalam S; Pal B
    Practitioner; 2000 Dec; 244(1617):1024-6, 1029-32. PubMed ID: 11220170
    [No Abstract]   [Full Text] [Related]  

  • 38. Refining drug safety in rheumatology.
    Cush JJ; Dao KH
    Rheum Dis Clin North Am; 2012 Nov; 38(4):xi-xiv. PubMed ID: 23137585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA).
    Verma S; Gupta R; Lodha R; Kabra SK
    Indian Pediatr; 2009 Mar; 46(3):264-5. PubMed ID: 19346579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
    Ferraccioli G; De Santis M; Tolusso B
    Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.